RAPT Therapeutics, Inc. (40)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated November 17, 2022
(Filed With SEC on November 22, 2022)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on November 10, 2022)
-
Offer Letter, by and between Karen Lam and RAPT Therapeutics, Inc., dated July 10, 2019
(Filed With SEC on March 30, 2020)
-
Collaboration and License Agreement, dated as of December 1, 2019, by and between Hanmi Pharmaceutical Co., LTD. and RAPT Therapeutics, Inc
(Filed With SEC on February 4, 2020)
-
Lease, by and between HCP, Inc. and Flexus Biosciences, Inc., dated October 10, 2014
(Filed With SEC on July 5, 2019)
-
Registration Rights Agreement, dated May 27, 2022, by and between RAPT Therapeutics, Inc. and the investor party thereto
(Filed With SEC on May 31, 2022)
-
Securities Purchase Agreement, dated May 24, 2022, by and between RAPT Therapeutics, Inc. and the investor party thereto
(Filed With SEC on May 31, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on May 31, 2022)
-
Underwriting Agreement, dated June 15, 2021
(Filed With SEC on June 16, 2021)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on March 30, 2020)
-
Description of Registrants Securities
(Filed With SEC on March 30, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on February 4, 2020)
-
Offer Letter by and between RAPT Therapeutics, Inc. and Rodney Young, dated as of November 11, 2019
(Filed With SEC on December 4, 2019)
-
Board of Directors Agreement, by and between Wendye Robbins and RAPT Therapeutics, Inc., dated October 11, 2019
(Filed With SEC on October 22, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on October 22, 2019)
-
Non-Employee Director Compensation Policy
(Filed With SEC on July 22, 2019)
-
Form of common stock certificate of RAPT Therapeutics, Inc
(Filed With SEC on July 22, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on July 22, 2019)
-
Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT Therapeutics, Inc
(Filed With SEC on July 22, 2019)
-
Employee Offer Letter, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March 17, 2016
(Filed With SEC on July 22, 2019)
-
RAPT Therapeutics, Inc. 2019 Equity Incentive Plan
(Filed With SEC on July 22, 2019)
-
Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2019 Equity Incentive Plan
(Filed With SEC on July 22, 2019)
-
Form of Restricted Stock Unit Award Agreement and Restricted Stock Unit Grant Notice under the 2019 Equity Incentive Plan
(Filed With SEC on July 22, 2019)
-
RAPT Therapeutics, Inc. 2019 Employee Stock Purchase Plan
(Filed With SEC on July 22, 2019)
-
Form of Indemnification Agreement by and between RAPT Therapeutics, Inc. and each of its directors and executive officers
(Filed With SEC on July 22, 2019)
-
Amended and Restated Employee Offer Letter, by and between Brian Wong and RAPT Therapeutics, Inc., dated July 20, 2019
(Filed With SEC on July 22, 2019)
-
Amended and Restated Employee Offer Letter, by and between William Ho and RAPT Therapeutics, Inc., dated July 20, 2019
(Filed With SEC on July 22, 2019)
-
Amended and Restated Employee Offer Letter, by and between Dirk Brockstedt and RAPT Therapeutics, Inc., dated July 20, 2019
(Filed With SEC on July 22, 2019)
-
Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March 19, 2019
(Filed With SEC on July 22, 2019)
-
Amendment to the Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated April 30, 2019
(Filed With SEC on July 22, 2019)
-
Board of Directors Agreement, by and between Linda Kozick and RAPT Therapeutics, Inc., dated November 15, 2016
(Filed With SEC on July 22, 2019)
-
Board of Directors Agreement, by and between Michael F. Giordano and RAPT Therapeutics, Inc., dated January 12, 2018
(Filed With SEC on July 22, 2019)
-
Board of Directors Agreement, by and between William Rieflin and RAPT Therapeutics, Inc., dated June 23, 2015
(Filed With SEC on July 22, 2019)
-
Amended and Restated Investors Rights Agreement by and among RAPT Therapeutics, Inc. and certain of its stockholders, dated December 18, 2018
(Filed With SEC on July 5, 2019)
-
Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT Therapeutics, Inc
(Filed With SEC on July 5, 2019)
-
Third Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated December 13, 2018
(Filed With SEC on July 5, 2019)
-
Second Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April 16, 2018
(Filed With SEC on July 5, 2019)
-
First Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April 29, 2015
(Filed With SEC on July 5, 2019)
-
RAPT Therapeutics, Inc. 2015 Stock Plan, as amended
(Filed With SEC on July 5, 2019)
-
Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2015 Stock Plan
(Filed With SEC on July 5, 2019)